Metabolomic Signatures of Extreme Old Age: Findings from the New England Centenarian Study
Authors:
- Stefano MontiSMStefano Monti
- Michael S. LustgartenMLMichael S. Lustgarten
- Ziwei HuangZHZiwei Huang
- Zeyuan SongZSZeyuan Song
- Dylan EllisDEDylan Ellis
- Qu TianQTQu Tian
- Luigi FerrucciLFLuigi Ferrucci
- Noa RappaportNRNoa Rappaport
- Stacy L. AndersenSAStacy L. Andersen
- Thomas P. PerlsTPThomas P. Perls
- Paola SebastianiPSPaola Sebastiani
Preprint
Abstract
The New England Centenarian Study (NECS) provides a unique resource for the study of extreme human longevity (EL). To gain insight into biological pathways related to EL, chronological age and survival, we used an untargeted serum metabolomic approach (> 1,400 metabolites) in 213 NECS participants, followed by integration of our findings with metabolomic data from four additional studies. Compared to their offspring and matched controls, EL individuals exhibited a distinct metabolic profile characterized by higher levels of primary and secondary bile acids – most notably chenodeoxycholic acid (CDCA) and lithocholic acid (LCA) – higher levels of biliverdin and bilirubin, and stable levels of selected steroids. Notably, elevated levels of both bile acids and steroids were associated with lower mortality. Several metabolites associated with age and survival were inversely associated with metabolite ratios related to NAD+ production and/or levels (tryptophan/kynurenine, cortisone/cortisol), gut bacterial metabolism (ergothioneine/ trimethylamine N-oxide, aspartate/quinolinate), and oxidative stress (methionine/methionine sulfoxide), implicating these pathways in aging and/or longevity. We further developed a metabolomic clock predictive of biological age, with age deviations significantly associated with mortality risk. Key metabolites predictive of biological aging, such as taurine and citrate, were not captured by traditional age analyses, pointing to their potential role as biomarkers for healthy aging. These results highlight metabolic pathways that may be targeted to promote metabolic resilience and healthy aging.Keywords
Funding Information
- National Institute on Aging (U19-AG023122)
- National Institute on Aging (U19-AG063893)
- National Institute on Aging (UH2-AG064704)
- National Institute on Aging (R01-AG061844)
This publication has 97 references indexed in Scilit:
- Gut microbiota in centenarians: A potential metabolic and aging regulator in the study of extreme longevityAging Medicine, 2024
- Ergothioneine promotes longevity and healthy aging in male miceGeroScience, 2024
- A metabolomic signature of the APOE2 alleleGeroScience, 2022
- The plasma metabolome as a predictor of biological aging in humansGeroScience, 2019
- From Lifespan to HealthspanJAMA, 2018
- Metabolomic approaches to the normal aging processMetabolomics, 2014
- Circulating acylcarnitines as biomarkers of mitochondrial dysfunction after acetaminophen overdose in mice and humansArchives of Toxicology, 2013
- The Hallmarks of AgingCell, 2013
- The influence of aging on the plasma concentration and renal clearance of homovanillic acidPsychoneuroendocrinology, 1994
- Effect of age on homovanillic and 4-hydroxy-3-methoxymandelic acid levels in plasmaEuropean Journal of Pediatrics, 1986